Cancer Family
Hepatobiliary Neoplasm
CI-CAN-00000198Explore in graph →
Non-malignant1,188 active trials17 approved drugs42 evidence items
- NCIt
- C8614
Loading cancer entity…
Cancer Family
CI-CAN-00000198Explore in graph →
Clinical trials
5,266 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01393093 | Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas(TACE-KMG) | unknown | N/A | 2,840 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT03178929 | Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma | unknown | N/A | 207 | Beijing Insight Science & Technology Co. Ltd.OTHER | 0 |
| Jun 7, 2017 |
| clinicaltrials |
| NCT03166436 | RFA for Malignant Biliary Obstruction | unknown | N/A | 140 | Institute for Clinical and Experimental MedicineOTHER_GOV | 1 | May 30, 2017 | clinicaltrials |
| NCT01798147 | Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC). | unknown | Phase 2 | 24 | Johannes Gutenberg University MainzOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT03161925 | Chinese Liver Cancer Clinical Survey(CLCS) | unknown | — | 5,000 | Beijing Insight Science & Technology Co. Ltd.OTHER | 0 | May 22, 2017 | clinicaltrials |
| NCT02550613 | Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT03114085 | Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 170 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 0 | May 15, 2017 | clinicaltrials |
| NCT03144856 | Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers | unknown | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02413437 | A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms | unknown | N/A | 2,088 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT03140007 | Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .(Cholangioscopy) | unknown | N/A | 60 | Asian Institute of Gastroenterology, IndiaOTHER | 0 | May 8, 2017 | clinicaltrials |
| NCT03138239 | The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG | unknown | N/A | 16 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | May 3, 2017 | clinicaltrials |
| NCT02568748 | Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC | unknown | Phase 3 | 20 | Sherief Abd-ElsalamOTHER | 1 | Apr 27, 2017 | clinicaltrials |
| NCT02420678 | Quality of Life in Patients With Hepatocellular Carcinoma | unknown | — | 300 | Asan Medical CenterOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT03130712 | A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) | unknown | Phase 1 / Phase 2 | 10 | Shanghai GeneChem Co., Ltd.INDUSTRY | 1 | Apr 26, 2017 | clinicaltrials |
| NCT02725996 | By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy | unknown | Phase 2 | 140 | Southwest Hospital, ChinaOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT03124498 | A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA | unknown | Phase 1 / Phase 2 | 55 | Chuan An Biotechnology Co., Ltd.INDUSTRY | 0 | Apr 21, 2017 | clinicaltrials |
| NCT03110068 | Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma | unknown | — | 370 | Ming KuangOTHER | 0 | Apr 12, 2017 | clinicaltrials |
| NCT03102268 | ncRNAs in Exosomes of Cholangiocarcinoma | unknown | — | 80 | The Second Hospital of Nanjing Medical UniversityOTHER | 1 | Apr 5, 2017 | clinicaltrials |
| NCT00730860 | Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE | unknown | N/A | 140 | Southwest Hospital, ChinaOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT03084380 | Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 20 | Xinqiao Hospital of ChongqingOTHER | 1 | Mar 20, 2017 | clinicaltrials |
| NCT03082378 | Central Obesity and Hepatocellular Carcinoma | unknown | — | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT01869088 | TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma | unknown | Phase 3 | 266 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2017 | clinicaltrials |
| NCT02729493 | Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer(EECLC) | unknown | N/A | 25 | Sinobioway Cell Therapy Co., Ltd.INDUSTRY | 1 | Mar 15, 2017 | clinicaltrials |
| NCT03069508 | Clemizole HCl for Subjects With Hepatocellular Carcinoma | unknown | Phase 2 | 12 | Eiger Group International, Inc.INDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03066557 | Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma | unknown | N/A | 80 | Jiangsu Cancer Institute & HospitalOTHER | 0 | Feb 28, 2017 | clinicaltrials |
| NCT02936856 | Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications(RDSA) | unknown | N/A | 200 | Guangxi Medical UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02956772 | Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 2 | 190 | Hunan Provincial People's HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01438385 | Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders | unknown | — | 12,000 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT01439698 | Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry(RFA-Registry) | unknown | — | 200 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT01522573 | T-EUS for Gastrointestinal Disorders: A Multicenter Registry(EUSERCPReg) | unknown | — | 1,000 | Weill Medical College of Cornell UniversityOTHER | 2 | Feb 20, 2017 | clinicaltrials |
| NCT01755013 | Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma | unknown | Phase 2 / Phase 3 | 55 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT02783261 | Prospective Post Y90 Liver Hypertrophy | unknown | — | 25 | Singapore General HospitalOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT03046979 | Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)(HCC) | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT03020342 | HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC | unknown | — | 50 | National Taiwan University HospitalOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT01966133 | TACE as an Adjuvant Therapy After Hepatectomy for HCC | unknown | Phase 3 | 280 | Jia FanOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT03010085 | Open Versus Laparoscopic Left-sided Hepatectomy Trial(OLLEH) | unknown | Phase 3 | 122 | Ewha Womans University Mokdong HospitalOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | unknown | Phase 2 | 54 | Sun Yat-sen UniversityOTHER | 1 | Dec 28, 2016 | clinicaltrials |
| NCT02742727 | CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT01642875 | Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy | unknown | Phase 4 | 96 | Medical University of WarsawOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02969096 | Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma | unknown | Phase 2 | 30 | Shanghai University of Traditional Chinese MedicineOTHER | 1 | Nov 21, 2016 | clinicaltrials |
| NCT02959151 | A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy | unknown | Phase 1 / Phase 2 | 20 | Shanghai GeneChem Co., Ltd.INDUSTRY | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02954302 | Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy | unknown | N/A | 140 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT02738697 | Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection | unknown | Phase 3 | 290 | Sun Yat-sen UniversityOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00606385 | Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC(HCC) | unknown | N/A | 84 | Seoul National University HospitalOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT01111591 | Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer | unknown | Phase 4 | 220 | Seoul National University HospitalOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02607826 | Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors | unknown | N/A | 298 | University Hospital TuebingenOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT02813096 | Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients | unknown | N/A | 500 | Guangxi Medical UniversityOTHER | 0 | Oct 25, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jun 12, 2017source: clinicaltrials